Product Information
LEVO-T 88 MCG TABLET is a generic product labeled by Neolpharma, Inc., priced at $0.0502 per EA under NDC 55466010711. Its NADAC has been published 525 times since Aug 3, 2016.
FDA first approved this application on Mar 1, 2002. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
88 ug/1
Manufacturer
Neolpharma, Inc.NDC
55466010711
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021342FDA Approved
3/1/2002
TE Code
AB1,AB2,AB3
On Market Since
10/29/2015
Pharmacological Classes
Price Statistics
The NADAC for LEVO-T 88 MCG TABLET has been published 525 times since Aug 3, 2016, and over the history we have for it it has declined 87.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0502 per EA |
|---|---|
| All-time high | $0.4013 (Aug 10, 2016) |
| All-time low | $0.0420 (May 22, 2024) |
| 52-week high | $0.0608 |
| 52-week low | $0.0502 |
| Median price | $0.2333 |
| Average price | $0.2144 |
| Largest weekly change | +55.7% (Jun 19, 2024) |
| Weeks tracked | 525 |
| Tracking since | Aug 3, 2016 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVO-T 88 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVO-T 88 MCG TABLET, manufactured by Neolpharma, Inc., is $0.0502 per EA (NDC 55466010711), effective Aug 19, 2026.
How has the price of LEVO-T 88 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVO-T 88 MCG TABLET has declined 87.5%. It has been tracked across 525 weekly CMS publications since Aug 3, 2016.
What are the highest and lowest recorded NADAC prices for LEVO-T 88 MCG TABLET?
Since Aug 3, 2016, the NADAC for LEVO-T 88 MCG TABLET has ranged from a low of $0.0420 (May 22, 2024) to a high of $0.4013 (Aug 10, 2016), with a median of $0.2333 per EA.
Are there cheaper alternatives to LEVO-T 88 MCG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVO-T 88 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVO-T 88 MCG TABLET?
LEVO-T 88 MCG TABLET (NDC 55466010711) is labeled by Neolpharma, Inc., and CMS classifies it as a generic product.